Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Acquisition

17 Sep 2007 07:01

Cello Group plc17 September 2007 17 September 2007 Cello Group plc Cello extends Response capability with the acquisition of Magnetic Cello Group plc ("Cello, AIM: CLL), the market research and consulting group hasacquired 100% of the share capital of Magnetic Advertising Company Limited ("Magnetic"), a specialist direct marketing support business. The initialconsideration consists of £1.25m, of which £0.55m is payable in cash and loannotes and the balance satisfied by the issue of 505,415 new Cello ordinaryshares. Further initial consideration of approximately £0.32m is expected to bepaid in cash and loan notes subject to verification of the net current assets ofMagnetic. In addition, there are further performance related considerationpayments of up to £2.75m payable by reference to the period to December 2010, ofwhich a minimum of 25% will be paid in the form of loan notes and the balance innew ordinary shares. For the year to 31 March 2007, Magnetic had turnover of £2.62m and operatingprofit of £0.48m. Net current assets acquired by Cello at completion areexpected to be approximately £0.57m including cash balances of approximately£0.40m. Application has been made to the London Stock Exchange for the new shares to beadmitted to AIM and it is expected admission will take place by 21 September2007. Mark Scott, Cello Chief Executive, said: "Response comprises approximately 25% of the Group's annual operating profit. Itis a dynamic, data based business benefiting from the shift of client spendtowards accountable, research based activity. Magnetic will strengthen ourposition with a range of existing and potential new clients in the UK." Enquiries: Cello Group plcMark Scott, Chief Executive 020 7812 8460 College HillAdrian Duffield/Rozi Morris 020 7457 2020 Notes to Editors (www.cellogroup.co.uk) Cello is a market research and consulting group that listed on AIM in November2004. The Group's strategy is to create value for shareholders by building aportfolio of research and consulting businesses capable of advising blue chipclients globally. Cello has annualised turnover in excess of £100million, operating income inexcess of £50 million and employs approx 650 professional staff. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Oct 20198:40 amRNSDisposal
18th Sep 20197:00 amRNSInterim Results
23rd Aug 201910:40 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSAcquisition of ISS
6th Aug 20193:07 pmRNSTotal Voting Rights
6th Aug 20197:00 amRNSNotification of Half Year Results
18th Jul 20197:00 amRNSPre-close Trading Update
20th Jun 20194:29 pmRNSDirector/PDMR Shareholding
10th Jun 20199:41 amRNSTotal Voting Rights
24th May 201912:45 pmRNSBlock listing Interim Review
20th May 20194:29 pmRNSIssue of Equity
15th May 20197:00 amRNSHolding(s) in Company
8th May 20191:30 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Statement
1st May 201912:15 pmRNSTotal Voting Rights
15th Apr 201911:12 amRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSCapital Markets Event
4th Apr 201910:00 amRNSTotal Voting Rights
27th Mar 20191:00 pmRNSHolding(s) in Company
21st Mar 20193:10 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSPreliminary Results
6th Mar 20191:51 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSNotice of Full Year Results
17th Jan 20197:00 amRNSPre-Close Trading Statement
14th Dec 20189:24 amRNSBlock Listing Update
23rd Nov 20183:45 pmRNSHolding(s) in Company
19th Nov 20182:45 pmRNSHolding(s) in Company
12th Nov 201811:30 amRNSDirectorate Change
5th Nov 20182:00 pmRNSDirectorate Change
31st Oct 20183:30 pmRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAppointment of Executive Director
25th Sep 20181:00 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 201811:39 amRNSTransfer of FTSE classification to Healthcare
21st Sep 201810:15 amRNSDirector/PDMR Shareholding
20th Sep 20184:00 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20187:00 amRNSInterim Results
22nd Aug 20181:51 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSNotification of Half Year Results
16th Aug 20182:00 pmRNSTotal Voting Rights
16th Aug 20181:30 pmRNSBoard Changes
23rd Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSPre-close Trading Update
17th Jul 20187:00 amRNSChange of registered office
4th Jul 20181:53 pmRNSHolding(s) in Company
27th Jun 201812:46 pmRNSHolding(s) in Company
22nd Jun 20184:47 pmRNSHolding(s) in Company
20th Jun 20182:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.